Overview of implantable cardioverter defibrillator and cardiac resynchronisation therapy in heart failure management.
Singapore Med J
; 57(7): 354-9, 2016 Jul.
Article
en En
| MEDLINE
| ID: mdl-27440409
ABSTRACT
Clinical trials have established the benefits of implantable cardioverter defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) in the treatment of heart failure patients. As adjuncts to guideline-directed medical therapy, ICDs confer mortality benefits from sudden cardiac arrest, while CRT reduces mortality, hospitalisation rates and improves functional capacity. This review discusses the use of ICDs and CRT devices in heart failure management, outlining the evidence supporting their use, indications and contraindications.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Desfibriladores Implantables
/
Terapia de Resincronización Cardíaca
/
Insuficiencia Cardíaca
Tipo de estudio:
Guideline
Límite:
Humans
País/Región como asunto:
Asia
Idioma:
En
Revista:
Singapore Med J
Año:
2016
Tipo del documento:
Article
País de afiliación:
Singapur